Overview
Clinical Benefits
- Strong pulsatile GH release
- Improved sleep + recovery
- Lean muscle support
- Fat loss
- Female-friendly (no virilization risk)
Administration
Subcutaneous injection — empty stomach preferred
Drug class: multi peptide blend
Clinical Dosing
Typical dosage
200mcg combined (100/100) per injection
Starting dose
100mcg combined (50/50)
Cadence
1-3x daily (pre-bed most common)
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-2 | 100mcg combined once daily pre-bed |
| Weeks 3-12 | 200mcg combined 2-3x daily (AM + pre-workout + pre-bed) |
| Weeks 13+ | Cycle off 4 weeks after 12-week run |
Safety Profile
Side effects
- • Injection site redness
- • Transient flushing
- • Mild headache
- • Vivid dreams
Contraindications
- • Active cancer
- • Pregnancy
- • Pituitary tumor
Do not combine with
Frequently asked questions
CJC-1295 + Ipamorelin Blend is most commonly researched for: Strong pulsatile GH release, Improved sleep + recovery, Lean muscle support, Fat loss.
Ready to build a protocol with CJC-1295 + Ipamorelin Blend?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.